Chromatography reagents market will witness substantial expansion over 2022-2028 owing to the surging number of pharma and biotech companies worldwide. The rising availability of funds from several organizations has made way for higher R&D expenditure on proteomics along with the growing purchasing power of well-established research institutes.
There is also a significant rise in the number of public-private investments in the pharmaceutical and life science research sectors. Chromatography reagents are extensively employed in the development of pure drug components as well as to measure the purity of the drugs.
However, the higher costs of these techniques to offer automated features and designs, and the dearth of skilled professionals? may pose as major hurdles for the market development to some extent.
In terms of type, chromatography reagents market size from the solvents segment, which is further bifurcated into high-pressure liquid chromatography (HPLC) grade solvents, gas chromatography (GC) grade solvents, and other solvents is slated to grow through 2022-2028. The HPLC grade solvents segment will expand with increasing penetration in environmental, chemicals, pharmaceutical, and forensics applications. These solvents are mostly utilized for limiting the baseline drifts, and detector noise, whilst enhancing the quality of data. Growing utility in quality control laboratories to offer effective reproducibility is another promising prospect for industry growth.
Based on application, the chromatography reagents industry share from the pharmaceutical testing segment is expected to rise with higher availability of government and corporate funding for pharmaceutical and biotechnology research activities. The incessant need for safe and effective drug products and rising technological advancements have led to the considerable expansion of the pharmaceutical sector. Chromatography techniques are witnessing higher adoption for identifying and analyzing the samples and detecting the mixture purities. The growing stringency of regulatory guidelines for drug development and safety, along with the surging number of clinical trial projects and R&D activities for therapeutic areas will further add to the segment growth.
Regionally, the chromatography reagents market in North America will expand with the fast-growing pharmaceutical sector, mainly in the U.S. The soaring government support, surge in number of drug development activities along with increasing incursion of technologically advanced solutions, have resulted in a higher count of clinical research studies. The booming geriatric population and rising burden of critical diseases have made way for significant healthcare expenditure in the region. The presence of a well-established R&D infrastructure coupled with rising investments for drug discovery and production has also favored the need for chromatography techniques and reagents. Growing penetration in the food & beverage and pharmaceutical sectors will drive the regional market growth.
Some of the major chromatography reagents industry participants include Bio-Rad Laboratories, Inc., Avantor Performance Materials, Inc. (Avantor), Santa Cruz Biotech, Inc., Merck Millipore (Merck Group), Regis Technologies, Inc., Sigma-Aldrich Corporation (Merck Group), Thermo Fisher Scientific, Inc., Loba Chemie, GE Healthcare (General Electric), and Linde.
Most of these health companies are taking up persistent efforts, including collaboration-oriented strategies, such as acquisitions and partnerships to amplify their global presence. They are also focusing on new product launches for expanding their portfolio and customer base.
For instance, in March 2020, Avantor, Inc. introduced PROchievA, a novel recombinant Protein A affinity chromatography resin for purifying antibodies during mAbs production. The novelty offers supply chain flexibility whilst improving the downstream purification performance.
In response to the COVID-19 crisis, chromatography reagents industry witnessed promising growth on account of significant advances in pharma and food & beverage sectors. The rising number of R&D activities in pharma and clinical labs for drug discovery and development added a positive edge to the use of several reagents and techniques. The growing adoption of Reversed-Phase Liquid Chromatography (RPLC) for accurately identifying the SARS-CoV-2 spike protein was another prominent factor that thrust a positive outlook on the market progression amidst the pandemic.